References
- Brix B, Sery O, Onorato A, et al. Biology of lymphedema. Biology. 2021;10(4):261.
- Kayiran O, De La Cruz C, Tane K, et al. Lymphedema: from diagnosis to treatment. Turk J Surg. 2017;33(2):51–57.
- Fu MR, Kang Y. Psychosocial impact of living with cancer-related lymphedema. Semin Oncol Nurs. 2013;29(1):50–60.
- Finnane A, Hayes SC, Obermair A, et al. Quality of life of women with lower-limb lymphedema following gynecological cancer. Expert Rev Pharmacoecon Outcomes Res. 2011;11(3):287–297.
- Han CW, Lee EJ, Iwaya T, et al. Development of the korean version of short-form 36-item health survey: health related QOL of healthy elderly people and elderly patients in Korea. Tohoku J Exp Med. 2004;203(3):189–194.
- Aaronson NK, Ahmedzai S, Bergman B, et al. The european organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376.
- Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–579.
- Keeley V, Crooks S, Locke J, et al. A quality of life measure for limb lymphoedema (LYMQOL). J Lymphoedema. 2010;5(1):26–37.
- Launois R, Mègnigbêto AC, Pocquet K, et al. A specific quality of life scale in upper limb lymphedema: the ULL-27 questionnaire. Lymphology. 2001;35(Suppl):1–760.
- Devoogdt N, Van Kampen M, Geraerts I, et al. Lymphoedema functioning, disability and health questionnaire (Lymph-ICF): reliability and validity. Phys Ther. 2011;91(6):944–957.
- Weiss J, Daniel T. Validation of the lymphedema life impact scale (llis): a condition-specific measurement tool for persons with lymphedema. Lymphology. 2015;48(3):128–138.
- van de Pas CB, Biemans AA, Boonen RS, et al. Validation of the lymphoedema quality-of-life questionnaire (LYMQOL) in dutch patients diagnosed with lymphoedema of the lower limbs. Phlebology. 2016;31(4):257–263.
- Wedin M, Fredrikson M, Ahlner E, et al. Validation of the lymphoedema quality of life questionnaire (LYMQOL) in swedish cancer patients. Acta Oncol. 2020;59(3):365–371.
- Yoshizawa T, Aoyama M, Takeishi Y, et al. Japanese version of the quality of life measurement for limb lymphedema (leg) (J-LYMQOL-1): its reliability and vality. Lymphoedema Res Pract. 2017;5(1):1–8.
- Bakar Y, Tugral A, Ozdemir O, et al. Translation and validation of the Turkish version of lymphedema quality of life tool (LYMQOL) in patients with breast cancer related lymphedema. Eur J Breast Health. 2017;13(3):123–128.
- Borman P, Yaman A, Denizli M, et al. The reliability and validity of lymphedema quality of life questionnaire-arm in Turkish patients with upper limb lymphedema related with breast cancer. Turk J Phys Med Rehab. 2018;64(3):205–212.
- Bakar Y, Tuğral A. Translation, reliability, and validation of the Turkish version of the lymphedema quality-of-life tool in Turkish-speaking patients with lower limb lymphedema. J Vasc Nurs. 2019;37(1):11–17.
- Borman P, Yaman A, Denizli M, et al. The reliability and validity of lymphedema quality of life questionnaire-leg in Turkish patients with lower limb lymphedema. Lymphat Res Biol. 2020;18(1):42–48.
- Monticone M, Ferriero G, Keeley V, et al. Lymphedema quality of life questionnaire (LYMQOL): cross-cultural adaptation and validation in italian women with upper limb lymphedema after breast cancer. Disabil Rehabil. 2022;44(15):4075–4080.
- Coriddi M, Dayan J, Sobti N, et al. Systematic review of patient-reported outcomes following surgical treatment of lymphedema. Cancers. 2020;12(3):565.
- Osborne JW, Costello AB. Sample size and subject to item ratio in principal components analysis. Pract Assess Res Evaluation. 2004;9(1):11.
- Yun YH, Park YS, Lee ES, et al. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res. 2004;13(4):863–868.
- Beaton DE, Bombardier C, Guillemin F, et al. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186–3191.
- Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–163.
- Cortina JM. What is coefficient alpha?: An examination of theory and applications. J Appl Psychol. 1993;78(1):98–99.
- Akoglu H. User's guide to correlation coefficients. Turk J Emerg Med. 2018;18(3):91–93.
- Smith SL, Bartlett WP, Gleeson PB, et al. Quality of life tools and their relevance for females with genital lymphedema. J Women’s Health Phys Ther. 2008;32(3):13–19.
- Weiss JM, Spray BJ. The effect of complete decongestive therapy on the quality of life of patients with peripheral lymphedema. Lymphology. 2002;35(2):46–58.
- Sitzia J, Sobrido L. Measurement of health-related quality of life of patients receiving conservative treatment for limb lymphoedema using the nottingham health profile. Qual Life Res. 1997;6(5):373–384.
- Viehoff PB, van Genderen FR, Wittink H. Upper limb lymphedema 27 (ULL27): dutch translation and validation of an illness-specific health-related quality of life questionnaire for patients with upper limb lymphedema. Lymphology. 2008;41(3):131–138.
- Devoogdt N, De Groef A, Hendrickx A, et al. Lymphoedema functioning, disability and health questionnaire for lower limb lymphoedema (Lymph-ICF-LL): reliability and validity. Phys Ther. 2014;94(5):705–721.
- De Vrieze T, Vos L, Gebruers N, et al. Revision of the lymphedema functioning, disability and health questionnaire for upper limb lymphedema (Lymph-ICF-UL): reliability and validity. Lymphat Res Biol. 2019;17(3):347–355.